SEVERANCE AGREEMENTSeverance Agreement • March 22nd, 2013 • Cell Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 22nd, 2013 Company Industry JurisdictionThis SEVERANCE AGREEMENT (the “Agreement”) is entered into by and between Cell Therapeutics, Inc., a Washington corporation (“CTI” or the “Company”), and Matthew Plunkett (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 28th, 2013 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
Contract Type FiledFebruary 28th, 2013 Company Industry JurisdictionThis SEVERANCE AGREEMENT (the “Agreement”) is entered into by and between Cell Therapeutics, Inc., a Washington corporation (“CTI” or the “Company”), and Steven E. Benner, M.D. (the “Executive”).